MPDU1 Antikörper (C-Term)

Produktnummer ABIN1881550

Produktdetails anti-MPDU1 Antikörper

Target: MPDU1 (Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Bindungsspezifität: AA 219-247, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MPDU1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This MPDU1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 219-247 amino acids from the C-terminal region of human MPDU1.

Klon: RB42402

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-MPDU1 Antikörper (ABIN1881550)

Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: "Genetic susceptibility to distinct bladder cancer subphenotypes." in: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).

Hosgood, Menashe, He, Chanock, Lan: "PTEN identified as important risk factor of chronic obstructive pulmonary disease." in: Respiratory medicine, Vol. 103, Issue 12, pp. 1866-70, (2009) (PubMed).

Shen, Vermeulen, Rajaraman, Menashe, He, Chapman, Yeager, Thomas, Burdett, Hutchinson, Yuenger, Chanock, Lan: "Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China." in: Environmental and molecular mutagenesis, Vol. 50, Issue 4, pp. 285-90, (2009) (PubMed).

Hosgood, Menashe, Shen, Yeager, Yuenger, Rajaraman, He, Chatterjee, Caporaso, Zhu, Chanock, Zheng, Lan: "Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway." in: Carcinogenesis, Vol. 29, Issue 10, pp. 1938-43, (2008) (PubMed).

Details zu MPDU1

Target: MPDU1 (Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Andere Bezeichnung: MPDU1 (MPDU1 Produkte)

Synonyme: CDGIF antikoerper, HBEBP2BPA antikoerper, Lec35 antikoerper, My008 antikoerper, PP3958 antikoerper, PQLC5 antikoerper, SL15 antikoerper, LEC35 antikoerper, Supl15h antikoerper, mpdu1 antikoerper, zgc:92112 antikoerper, MPDU1 antikoerper, DDBDRAFT_0237930 antikoerper, DDB_0237930 antikoerper, fb18d03 antikoerper, wu:fb18d03 antikoerper, zgc:86765 antikoerper, mannose-P-dolichol utilization defect 1 antikoerper, mannose-P-dolichol utilization defect 1a antikoerper, cystinosin/ERS1p repeat-containing protein antikoerper, mannose-P-dolichol utilization defect 1b antikoerper, MPDU1 antikoerper, Mpdu1 antikoerper, mpdu1a antikoerper, mpdu1 antikoerper, LOC692905 antikoerper, mpdu1b antikoerper

Hintergrund: This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants.

Molekulargewicht: 26638

NCBI Accession: NP_004861

UniProt: O75352